论文部分内容阅读
32例2型糖尿病随机分为MDI和CSII两组。结果:治疗前后比较显示:两组均能降低空腹(FPG)和餐后血糖(PPG)以及升高空腹(FCP)和餐后2小时C-肽(P<0.01);两组之间比较显示:与MDI组比较,CSII组对空腹、餐后血糖以及空腹、餐后2小时C-肽的改善更明显(P<0.05),血糖达标所需时间和所耗胰岛素用量少(P<0.01),所需住院时间短(P<0.01),日平均费高(P<0.01),但两组住院总费用无差异(P>0.05),且间接经济损失明显减少(P<0.01)。结论:CSII具有平稳快速控制血糖、减少胰岛素用量、缩短住院时间,且不增加患者的经济负担等特点。
32 cases of type 2 diabetes were randomly divided into MDI and CSII two groups. Results: Before and after treatment, both FPG and PPG, FCP and 2-hour postprandial C-peptide were lower in both groups (P <0.01) Compared with MDI group, the CSII group had more significant improvement on fasting and postprandial blood glucose, fasting and postprandial 2-hour C-peptide (P <0.05), less time required for blood glucose compliance and less insulin consumption (P <0.01) ). The required hospitalization time was shorter (P <0.01) and the average daily cost was higher (P <0.01). However, there was no difference in the total cost of hospitalization between the two groups (P> 0.05) and the indirect economic loss was significantly reduced (P <0.01). CONCLUSIONS: CSII has smooth and rapid control of blood glucose, insulin dosage, shorten the hospital stay, and does not increase the economic burden of patients and so on.